Key Sessions
Ruiz Astigarraga
Galapagos' Innovative Decentralized Manufacturing Model for Cell Therapy
Galapagos
Jordan Schecter
Cilta-cel: The Story of a llama-inspired, autologous CAR-T product for Multiple Myeloma
Johnson & Johnson
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 4th December – Day 2 Main Conference - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Wednesday 4th December – Day 2 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Showing 1 of 1 Streams
Registration
08:00 - 08:55
Registration & Coffee
Showing 2 of 2 Streams
Cell Therapy
Gene Therapy
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
Cilta-cel: The Story of a llama-inspired, autologous CAR-T product for Multiple Myeloma
- Jordan Schecter - VP, Multiple Myeloma, Johnson & Johnson
09:30 - 10:00
CoStARTM, a Chimeric Costimulatory Antigen Receptor, Enhances Anti-Tumour Activity of Tumour-Infiltrating Lymphocytes
- John Bridgeman - Director of Cell Therapy Research, Instil Bio
10:00 - 10:30
Spotlight Presentation
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
Successful multi sites upstream process development of a gene therapy product from bench scale to manufacturing scale
- Giovanni Ganendra - Senior Scientist - Gene Therapy Process and Analytical Sciences, UCB Pharma
09:30 - 10:00
Latest developments in solving the problem of AAV neutralising antibodies through physical depletion using magnetic haemofiltration
- Dr George Frodsham - Founder & CEO, Medisieve
10:00 - 10:30
Spotlight Presentation
Showing 1 of 1 Streams
Networking Break
10:30 - 11:00
Morning Break
Showing 2 of 2 Streams
Cell Therapy
Gene Therapy
11:00 - 11:30
From Cutting-Edge to Approved: Building The Regulatory Playbook for Cell Therapies
- Florence Salmon - VP Regulatory Affairs, HOOKIPA Pharma Inc.
11:00 - 11:30
EPI-321 Scaling Challenges: Considerations Required for a Robust AAVrh74 Manufacturing Process
- Surabhi Godbole - Associate Scientist Process Development, Epic Bio
Showing 2 of 2 Streams
Cell Therapy
Tech Slam
11:30 - 12:30
How can Decentralized Manufacturing be Implemented at Patient Point-of-care?
- Unique regulatory requirements for decentralized cell therapy manufacturing models
- Differing healthcare systems across global regions, how can we harmonize?
- Update from local municipalities on work done so far
- Dialogue and collaboration between developer/practitioner to streamline eventual implementation
- Improving access to third-world/underdeveloped countries: how can manufacturers help?
- Ruiz Astigarraga - Head of Manufacturing - Cell Therapy, Galapagos
11:30 - 12:30
Cutting Through the Noise: Choosing the Right Tools Beyond Buzzwords in a Crowded Market
Join us for our Tech Slam series of quickfire showcases highlighting the cutting-edge technologies to streamline the development & manufacturing of your novel therapeutics
Showing 1 of 1 Streams
Networking Break
12:30 - 13:30
Lunch
Showing 2 of 2 Streams
Cell Therapy
Gene Therapy
13:30 - 14:00
Realising the Promise of Stem Cell Therapies: A Pluripotent Allogeneic Approach
- Kristian Tryggvason - Co-Founder, CEO, Alder Therapeutics
14:00 - 14:30
New class of Antigen-specific Cancer Active Immunotherapies based on an off-the-shelf Antigen Presenting Cell line (PDC*line)
- Eric Halioua - President & Chief Executive Officer, PDC*line Pharma
14:30 - 15:00
Spotlight Presentation
13:30 - 14:00
Build or Buy? Optimising the route to GMP Readiness
- Evaluation of in-house expertise, infrastructure, and capacity for GMP manufacturing to transition towards commercial readiness.
- Addressing potential risks of outsourcing and building contingency plans
- Successful case study example of outsourcing vs in-house
14:00 - 14:30
Challenges and Strategies in Host Cell Protein Analysis for Gene Therapy Products
- Alok Tanala Patra - Scientist, A*STAR Bioprocessing Technology Institute
14:30 - 15:00
Spotlight Presentation
Showing 1 of 1 Streams
Networking Break
15:00 - 15:30
Afternoon Break
Showing 1 of 1 Streams
Keynote Plenary
15:30 - 16:15
Galapagos' Innovative Decentralized Manufacturing Model for Cell Therapy
- Ruiz Astigarraga - Head of Manufacturing - Cell Therapy, Galapagos
16:15 - 16:45
Fuelling Funding: Securing the Future Innovation and Development of Advanced Therapies
- Current funding landscape: VC, Angel, Grants, etc.
- Innovative funding mechanisms to balance risk and reward for investors and developers.
- Recovering from the Covid Bubble bursting
- Ensuring equitable access to advanced therapies across different economic landscapes
- The role of patient advocacy in shaping funding priorities and influencing investment decisions
- How can angel investors with smaller individual investments can work with larger VCs ticket size? Can these individual investors bring an insight that VCs don’t/can’t have?
- Hiroyuki Usuda - Scouting & Innovation Management Manager, Astellas Innovation Management LLC
- Eric Halioua - President & Chief Executive Officer, PDC*line Pharma
- Sven Kili, MD - Partner, Saisei Ventures
Showing 1 of 1 Streams
Networking Break
16:45 - 16:50
Close of Conference
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams